Vallon-Christersson J

The DNA methylation landscape of primary triple-negative breast cancer.

Aine M, Nacer DF, Arbajian E, ..., Borg Å, Staaf J

Nat Commun 16 (1) 3041 [2025-03-28; online 2025-03-28]

Multiomic profiling of metastatic potential in estrogen receptor-positive human epidermal growth factor-negative breast cancer

Mosquim S, Zamore M, Vallon-Christersson J, Rydén L, Levander F

- - (-) - [2025-01-23; online 2025-01-23]

Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery.

Mosquim Junior S, Siino V, Rydén L, Vallon-Christersson J, Levander F

Cancers (Basel) 14 (23) - [2022-11-23; online 2022-11-23]

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.

Lauss M, Donia M, Harbst K, ..., Svane IM, Jönsson G

Nat Commun 11 (1) 1714 [2020-04-01; online 2020-04-01]

Multidimensional transcriptomics provides detailed information about immune cell distribution and identity in HER2+ breast tumors

Salmén F, Vickovic S, Larsson L, ..., Ståhl PL, Lundeberg J

- - (-) - [2018-06-29; online 2018-06-29]

Sanja Vickovic SciLifeLab Fellow

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.

Lauss M, Donia M, Harbst K, ..., Svane IM, Jönsson G

Nat Commun 8 (1) 1738 [2017-11-23; online 2017-11-23]